Moneycontrol
HomeNewsBusinessEconomyExclusive | Government plans to shut down 'redundant bodies' to rationalise cost
Trending Topics

Exclusive | Government plans to shut down 'redundant bodies' to rationalise cost

The Union Textile Ministry in August abolished the All India Handicrafts Board and the All India Handloom Board — advisory bodies that were created to help the government in “formulation of the overall development programmes” in the handicrafts and handloom sectors, “keeping in view socio-economic cultural and artistic perspective”.

October 08, 2020 / 14:55 IST
Story continues below Advertisement
Economic activity across India has taken a hit due to the ongoing COVID-19 pandemic. Businesses and industries have remained shuttered for over two months now amid the ongoing nationwide lockdown. Even as restrictions have been eased across some parts of the country, especially with respect to domestic travel and business operations, states with a higher case burden are struggling to deal with the crisis. Highlighting the grave economic impact of COVID-19, CRISIL has said India is staring at its worst recession since Independence. Here are its impact on key indicators:

As part of the larger plan to tackle the economic fallout of the COVID-19 pandemic, the government is planning to shut down almost a dozen autonomous bodies to rationalise costs.

Some of the autonomous bodies that might be shut down are the National Productivity Council (NPC) and the Tariff Commission, among others, Moneycontrol has learnt.

Story continues below Advertisement

"The National Productivity Council employs about two hundred people and literally nobody in the government knows what it does," a senior government official told Moneycontrol.

NPC, established in the year 1958, is an autonomous organisation under Department for Promotion of Industry and Internal Trade. Besides undertaking research in the area of productivity, NPC has been providing consultancy and training services in areas of industrial engineering, agri-business, and economic services, among others.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show